FormFactor

Overview

FormFactor, Inc. (NASDAQ: FORM) is a leading supplier of semiconductor wafer probe cards and precision test and measurement equipment, with an increasingly significant footprint in the quantum computing supply chain through its cryogenic probe and cryogenic systems businesses. Founded in 1993 and headquartered in Livermore, California, FormFactor is best known to mainstream semiconductor investors for its probe card franchises serving DRAM, Flash, and advanced logic customers at foundries and IDMs globally. However, the company's strategic positioning in quantum computing rests on two distinct pillars: its Cryogenic Probe Systems (CPS) product line, which enables wafer-level characterization of quantum devices at millikelvin temperatures, and its 2019 acquisition of High Precision Devices (HPD), a Boulder, Colorado-based specialist in ultra-low-temperature cryogenic systems including dilution refrigerators and custom cryostats used in quantum research and computing.

The core technology thesis for FormFactor in quantum computing is that semiconductor-style manufacturing discipline must eventually be applied to the fabrication and test of superconducting and other solid-state qubit devices. Today, most quantum hardware companies characterize qubits one device at a time using bespoke cryogenic setups — an extraordinarily slow and expensive process. FormFactor's CPS tools, built on the company's expertise in precision probe positioning and its HPD cryogenic know-how, are designed to allow wafer-level, parallel probing of quantum devices at operating temperatures down to ~10 millikelvin. This would compress device characterization timelines dramatically and is a prerequisite for any volume manufacturing ramp of superconducting qubit chips. The value proposition is directly analogous to FormFactor's role in classical semiconductor development: enabling yield learning and production test at scale.

Commercially, FormFactor serves quantum hardware developers — including government-funded national labs such as Sandia and NIST, university research groups, and increasingly commercial players such as IBM, Google, and their supply chains — with cryogenic probing solutions that are unique in the market for combining wafer-scale access with milli-Kelvin temperatures. The HPD division also generates revenue from custom cryogenic systems and dilution refrigerators for broader research applications. Quantum computing remains a small but strategically important and high-growth segment within FormFactor's overall revenue mix, with management having called it out as a multi-year investment thesis tied to the scaling of solid-state qubit manufacturing.

In the competitive landscape, FormFactor occupies a distinctive niche. No other publicly traded company offers a directly comparable cryogenic wafer probing capability. Its closest analogues in the cryogenic infrastructure space — Oxford Instruments, Bluefors, Leiden Cryogenics — are private or division-level competitors focused on dilution refrigerators for end-use quantum systems rather than wafer-level test. FormFactor benefits from existing relationships with semiconductor customers who are now building quantum hardware, and from the broader credibility and balance sheet of a $600M+ revenue public company backing a niche but strategically vital product line.

Leadership

Technology

FormFactor's quantum-relevant technology divides into two complementary capabilities. The first is its Cryogenic Probe Systems product line, which adapts FormFactor's core probe card and precision positioning expertise to operation at cryogenic temperatures. The flagship CPS tool is designed to contact wafer-scale superconducting qubit devices at temperatures down to approximately 1 Kelvin in its standard configuration, with advanced configurations and HPD-derived sub-systems enabling operation at millikelvin temperatures relevant to transmon and other superconducting qubit architectures. The system incorporates low-vibration mechanical design, RF and microwave signal routing optimized for qubit readout frequencies (typically 4–8 GHz), and custom probe tips designed for high-fidelity electrical contact without damaging fragile superconducting film structures. The value of wafer-level probing at these temperatures is that it enables statistical characterization across many devices on a single wafer in a single cooldown cycle, replacing weeks of individual device packaging and testing with a workflow that is orders of magnitude faster.

The second capability is FormFactor's HPD division, which designs and builds custom cryogenic systems including dilution refrigerators, adiabatic demagnetization refrigerators (ADRs), and custom cryostats for quantum computing and quantum sensing applications. HPD systems have been deployed at national laboratories, universities, and commercial quantum hardware developers. The dilution refrigerators produced by HPD are competitive with those from European leaders (Oxford Instruments' Triton series, Bluefors LD/XLD series) and serve both research and quantum computing production use cases. HPD also supplies custom cryogenic test fixtures and specialized inserts for quantum hardware characterization, complementing the CPS probe system. Together, these two capabilities position FormFactor as a cryogenic infrastructure provider across the full arc from wafer-level R&D test to system-level quantum computing hardware.

Key Systems

• Cryogenic Probe System (CPS) — wafer-level probe system operating at sub-Kelvin to millikelvin temperatures for superconducting qubit characterization
• HPD Dilution Refrigerators — custom dilution refrigerator systems for quantum computing research and hardware testing
• HPD Adiabatic Demagnetization Refrigerators (ADRs) — sub-Kelvin cooling systems for quantum sensing and space applications
• Custom Cryogenic Test Fixtures and Inserts — bespoke cryogenic hardware for qubit characterization and quantum device integration

Performance Highlights

• CPS system demonstrated wafer-level probing of superconducting qubit devices at temperatures relevant to qubit operation (millikelvin range achievable with HPD insert integration)
• HPD dilution refrigerators achieve base temperatures below 10 millikelvin, consistent with requirements for transmon and other superconducting qubit architectures
• FormFactor has publicly cited the CPS as enabling characterization of hundreds of qubit devices per wafer per cooldown cycle, compared to weeks-per-device in conventional packaged-device test flows
• HPD systems deployed at multiple U.S. Department of Energy national laboratories and NIST, validating system performance in demanding research environments

Financials

FormFactor is a well-established public company with a substantial revenue base from its traditional probe card and semiconductor test equipment businesses. Total company revenue for fiscal year 2024 was approximately $700–720 million (precise figures subject to final reporting; the company has guided to this range), with the large majority derived from its probe card segments serving DRAM, Flash, and advanced foundry logic customers. The quantum and cryogenic segment, which FormFactor reports within its Systems segment alongside other non-probe-card businesses, is estimated to contribute in the range of $30–60 million annually — a small but growing fraction of total revenue. The company is consistently profitable on an adjusted basis, with gross margins typically in the 40–45% range, and generates positive operating cash flow, giving it financial stability uncommon among pure-play quantum companies.

FormFactor's balance sheet is conservatively managed, with moderate debt and a cash and equivalents position typically in the $100–150 million range. The company has historically deployed capital via acquisitions (HPD in 2019 being the most quantum-relevant), R&D investment, and share repurchases. Capital expenditure requirements are relatively modest for a precision equipment manufacturer. The market capitalization has fluctuated considerably with semiconductor cycle sentiment — ranging from approximately $1.5 billion to over $3 billion in recent years — meaning the quantum upside optionality is embedded in a business that trades primarily on conventional semiconductor test and measurement multiples. This creates both an opportunity (quantum exposure at a discount to pure-plays) and a risk (quantum narrative drowned out by probe card cycle dynamics).

The company does not break out quantum-specific revenue with precision, which limits investor ability to track the segment's growth rate independently. Management has described quantum as a long-term investment consistent with the company's broader strategy of enabling the development and manufacturing scale-up of advanced semiconductor devices, and has not given specific quantum revenue guidance. Analyst coverage focuses primarily on the probe card business, and FormFactor trades at earnings multiples typical of semiconductor capital equipment companies rather than quantum premium multiples.

Key Figures

• Estimated total FY2024 revenue: approximately $700–720 million (semiconductor test equipment, primarily probe cards)
• Quantum/cryogenic segment revenue: estimated $30–60 million annually (FormFactor does not separately disclose this figure with precision)
• Adjusted gross margin: approximately 40–45% range, consistent over recent years
• Market capitalization: approximately $1.5–2.0 billion as of early 2026 (subject to market fluctuations)
• HPD acquisition completed 2019 for an undisclosed sum estimated in the low tens of millions of dollars
• Cash and equivalents: approximately $100–150 million (approximate, based on recent balance sheet filings)

Milestones

Roadmap

FormFactor has not published a quantum-specific technology roadmap with the granularity that pure-play quantum hardware companies typically provide — its quantum strategy is embedded within a broader product development agenda tied to enabling the scaling of quantum device manufacturing. The stated direction is to extend the CPS platform's capabilities to support larger wafer sizes (moving from early 2-inch and 4-inch quantum wafers toward the 200mm and eventually 300mm formats that mature quantum manufacturing will require), lower achievable base temperatures in production-viable configurations, and higher probe tip densities to support characterization of more complex multi-qubit device arrays in a single measurement setup. Management has indicated that the CPS roadmap tracks the manufacturing readiness trajectory of leading superconducting qubit developers, with the implicit assumption that commercial volume manufacturing of superconducting qubit chips on 200mm wafers is a 3–7 year horizon from approximately 2023.

On the HPD side, the roadmap focuses on modular, higher-throughput dilution refrigerator systems optimized for quantum hardware test and production environments rather than purely research use cases. This includes systems with faster cooldown cycles, higher cooling power budgets to support larger qubit arrays with more signal wiring, and improved vibration isolation. FormFactor has not specified target cooling power figures or cooldown cycle times publicly with precision, but the direction aligns with the requirements being articulated by commercial quantum hardware developers as they scale from tens to hundreds to thousands of physical qubits per chip. No significant timeline slippage has been publicly disclosed, though the dependency on broader quantum hardware manufacturing timelines — which have generally been revised later industry-wide — represents an implicit schedule uncertainty. The company has been deliberately measured in its quantum revenue projections, which is appropriate given the early stage of the market but limits the visibility investors have into the segment's growth trajectory.

Competitive Position

FormFactor's competitive position in quantum cryogenic infrastructure is genuinely differentiated at the wafer-level probe system level. No other company offers a comparable commercially available system for wafer-scale characterization of superconducting qubit devices at millikelvin temperatures with the precision positioning and RF signal integrity required for meaningful qubit measurement. Potential competitors would need to combine deep cryogenic engineering expertise with precision semiconductor probe technology — a combination that does not exist in a directly competing product. The most plausible competitive threats come from: (1) internal development by large quantum hardware companies (IBM, Google, Intel) who could develop proprietary wafer-level test capabilities, bypassing third-party suppliers; and (2) European cryogenic instrument companies such as Oxford Instruments or Bluefors potentially extending their product lines into wafer-level probing. Neither threat appears imminent based on publicly available information as of early 2026.

In the dilution refrigerator segment, the competitive landscape is more crowded. Bluefors (Finnish, private) is widely regarded as the market leader for quantum computing dilution refrigerators on a global basis, with Oxford Instruments (UK-listed) and Leiden Cryogenics also serving the market. HPD competes primarily in the U.S. market where domestic supply chain preferences (particularly for government-funded programs) provide a degree of protection. FormFactor's HPD division is a credible but not dominant player in this segment, and its differentiation rests on custom engineering capability and U.S.-based manufacturing rather than volume scale. The overall competitive dynamic for FormFactor in quantum is one of early-mover advantage in a niche that is currently small but strategically positioned for significant growth — the risk being that larger players or vertically integrated quantum hardware companies eventually commoditize or internalize the capability.

Risks & Opportunities

Investment Considerations